Literature DB >> 21840394

The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.

Zakaria Y Abd Elmageed1, Amarjit S Naura, Youssef Errami, Mourad Zerfaoui.   

Abstract

Post-transcriptional modification of proteins is crucial for balancing protein structure and function in many biological processes. The addition of polymers of adenosine diphosphate (ADP)-ribose (PAR), which are synthesized by PAR polymerases (PARPs) from nicotinamide adenine dinucleotide (NAD), is one such distinctive post-translational modification. PARP-1, the best characterized of the 17-member PARP family, is considered a key isoform responsible for poly(ADP-ribosyl)ation of several nuclear proteins. ADP-ribose polymers add a highly negative charge to their target proteins, resulting in a modification of their activities and functions. PARPs not only participate in regulating cell survival and cell death programs, but are also involved in other biological functions with which novel members of the PARP family have been shown to be involved. Among such functions are transcription regulation, telomere cohesion and mitotic spindle formation during cell division, and intracellular energy metabolism. Recent work from our laboratory and others has highlighted the novel role of PARP-1 in regulating the intracellular trafficking of key cellular proteins such as p53 and nuclear factor-kappa B (NF-κB). Recent literature has revealed that ADP-ribosylation reactions may play important roles in cellular trafficking during inflammation, cell death, and DNA repair. This review will summarize recent findings and concepts linking the role of PARP enzymes and their poly-ADP-ribosylation activity in the regulation of intracellular transport processes. A special focus is placed on the proposed molecular mechanisms involved in such transport processes as the functional significance of PARylation of p53, NF-κB, and high-mobility group protein box 1.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840394     DOI: 10.1016/j.cellsig.2011.07.019

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  35 in total

1.  3-Aminobenzamide Prevents Concanavalin A-Induced Acute Hepatitis by an Anti-inflammatory and Anti-oxidative Mechanism.

Authors:  Joram Wardi; Orna Ernst; Anna Lilja; Hussein Aeed; Sebastián Katz; Idan Ben-Nachum; Iris Ben-Dror; Dolev Katz; Olga Bernadsky; Rajendar Kandhikonda; Yona Avni; Iain D C Fraser; Roy Weinstain; Alexander Biro; Tsaffrir Zor
Journal:  Dig Dis Sci       Date:  2018-09-08       Impact factor: 3.199

2.  HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts.

Authors:  Aya Masaoka; Natalie R Gassman; Padmini S Kedar; Rajendra Prasad; Esther W Hou; Julie K Horton; Michael Bustin; Samuel H Wilson
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

3.  Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling.

Authors:  Paola Castri; Yang-Ja Lee; Todd Ponzio; Dragan Maric; Maria Spatz; Joliet Bembry; John Hallenbeck
Journal:  Biochim Biophys Acta       Date:  2014-03

4.  The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.

Authors:  David Davidson; Yunzhe Wang; Raquel Aloyz; Lawrence Panasci
Journal:  Invest New Drugs       Date:  2012-10-09       Impact factor: 3.850

5.  Thioredoxin-interacting protein mediates nuclear-to-plasma membrane communication: role in vascular endothelial growth factor 2 signaling.

Authors:  Oded N Spindel; Chen Yan; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-16       Impact factor: 8.311

6.  High content organelle trafficking enables disease state profiling as powerful tool for disease modelling.

Authors:  Arun Pal; Hannes Glaß; Marcel Naumann; Nicole Kreiter; Julia Japtok; Ronny Sczech; Andreas Hermann
Journal:  Sci Data       Date:  2018-11-13       Impact factor: 6.444

7.  Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis.

Authors:  Aparna Raghavan; Zahoor A Shah
Journal:  Mol Neurobiol       Date:  2014-10-08       Impact factor: 5.590

8.  Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib.

Authors:  Titto Augustine; Radhashree Maitra; Jinghang Zhang; Jay Nayak; Sanjay Goel
Journal:  Invest New Drugs       Date:  2019-01-05       Impact factor: 3.850

Review 9.  Overview of pyridine nucleotides review series.

Authors:  Michinari Nakamura; Aruni Bhatnagar; Junichi Sadoshima
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

10.  Broadening the scope of glycosyltransferase-catalyzed sugar nucleotide synthesis.

Authors:  Richard W Gantt; Pauline Peltier-Pain; Shanteri Singh; Maoquan Zhou; Jon S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.